Stacey DaCosta Byfield

Author

Also Known As

S BYFIELD, S Byfield, S DaCosta Byfield, S Dacosta Byfield, S. DaCosta Byfield, S. Dacosta Byfield, STACEY DACOSTA BYFIELD, Stacey Byfield, Stacey D. Byfield, Stacey DaCosta Byfield

Publications

Citations

H-Index

Concepts

All Affiliations

Optum (United States)National Cancer Institute Eli Lilly (United States)Memorial Sloan Kettering Cancer Center National Institutes of Health

About

Stacey DaCosta Byfield is an author at Optum (United States) specializing in breast cancer, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	256
2	Public Health	1	1	239
3	Health Policy	1	1	17
4	Surgical Oncology	1	1	17
5	Molecular Oncology	1	1	239

Stacey DaCosta Byfield

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7 Stacey DaCosta Byfield, Christopher Major, Nicholas J. Laping, Molecular Pharmacology	2004	412
Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk Douglas E. Levy, Stacey DaCosta Byfield, Catherine Comstock, Genetics in Medicine Hispanic WomenBreast OncologyCancer RiskCancer ScreeningMedicine	2011	239
Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β Christina H. Stuelten, Stacey DaCosta Byfield, Praveen Arany, Journal of Cell Science	2005	236
Loss of Smad3 in Acute T-Cell Lymphoblastic Leukemia Lawrence A. Wolfraim, Tania Miñes Fernández, Mizuko Mamura, New England Journal of Medicine	2004	164
Smad-Binding Defective Mutant of Transforming Growth Factor β Type I Receptor Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines Fang Tian, Stacey DaCosta Byfield, W. Tony Parks, Cancer Research	2004	83
A retrospective analysis of delays in the diagnosis of lung cancer and associated costs Thomas R. Gildea, Stacey DaCosta Byfield, D. Kyle Hogarth, ClinicoEconomics and Outcomes Research	2017	82
Age distribution of patients with advanced non-melanoma skin cancer in the United States Stacey DaCosta Byfield, Diana Chen, Yeun Mi Yim, Archives of Dermatological Research	2013	63
Cost-effectiveness Analysis of a Randomized Study Comparing Radiosurgery With Radiosurgery and Whole Brain Radiation Therapy in Patients With 1 to 3 Brain Metastases Lincy S. Lal, Stacey DaCosta Byfield, Eric L. Chang, American Journal of Clinical Oncology	2011	48
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer Nicole Engel-Nitz, Stacey DaCosta Byfield, Arliene Ravelo, The Oncologist	2019	36
ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study Stacey DaCosta Byfield, Philip O. Buck, Cori Blauer‐Peterson, Journal of Oncology Practice	2016	24

Page 1